|
시장보고서
상품코드
2091941
백일해 백신 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 백신 유형별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Pertussis Vaccine Market Size, Share, and Growth Analysis, By Product Type, By Vaccine Type, By Application, By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 백일해 백신 시장 규모는 2024년에 50억 7,000만 달러로 평가되며, 2025년 52억 6,000만 달러에서 2033년까지 70억 9,000만 달러로 확대하며, 예측 기간(2026-2033년)에 CAGR 3.8%로 성장할 것으로 전망되고 있습니다.
전 세계 백일해 백신 시장은 다양한 경제권 간의 규제 체계 조화를 통해 상당한 성장이 예상됩니다. 이러한 추세로 인해 제약사의 시장 진입이 가속화되고 개발 비용이 절감됨에 따라 백신 후보 물질에 대한 투자가 증가하게 될 것입니다. 주요 규제 당국의 승인 절차 효율화는 무세포 제제의 매력을 높이고 있으며, 신흥 시장에서 생명공학 기업과 백신 제조사 간의 전략적 제휴가 그 대표적인 사례입니다. 이러한 제휴는 위험에 처한 사람들에게 더 많은 접근 기회를 제공할 뿐만 아니라, 안정적인 수입원을 창출하고, 업계의 회복력을 지원하며, 연구개발 활동을 촉진합니다. 결국, 시장을 주도하고 전 세계 공중보건 성과를 향상시키는 데 기여하게 됩니다.
세계 백일해 백신 시장의 성장 요인
전 세계 백일해 백신 시장은 특히 신생아의 백일해로 인한 중증 합병증에 대한 일반 대중의 인식이 높아짐에 힘입어 인상적인 성장을 달성하고 있습니다. 헬스케어 캠페인과 언론 보도를 통해 이 문제가 부각됨에 따라 학부모와 의료 종사자 모두 백신 접종이 확실하게 이루어지도록 더욱 주력하고 있습니다. 안전하고 효과적인 백일해 백신에 대한 이러한 수요는 제약사들이 생산 능력을 강화하고 새로운 제제를 개발하는 원동력이 되고 있습니다. 예방접종 체계 전체가 널리 받아들여짐에 따라 선순환이 형성되어, 다양한 지역의 성장을 촉진하는 동시에 공중보건 성과 향상과 지속가능한 질병 대책 추진이 가능해졌습니다.
세계 백일해 백신 시장의 제약 요인
전 세계 백일해 백신 시장은 백신의 안전성에 대한 특정 학부모층의 지속적인 우려와 더불어, 백일해 예방접종을 둘러싼 오해로 인해 제약을 받고 있습니다. 이러한 우려는 예방접종 일정의 지연이나 완전한 거부로 이어지며, 결국 시장 전체의 수요를 감소시키고 있습니다. 백신에 대한 신뢰 부족은 신제품 개발에 대한 투자 의지를 약화시키고, 이 질환을 억제하기 위한 보건 정책의 성공을 저해하고 있습니다. 그 결과, 제조사들은 예측 불가능한 판매 패턴에 직면하는 한편, 보건 당국은 인식 제고 캠페인에 추가 자원을 투입할 수밖에 없게 되어 시장 성장을 저해하고 있습니다. 이러한 불확실성은 유통 네트워크의 장기적인 계획 수립을 복잡하게 만들며, 기업은 지역별 백신 접종률의 변동에 따라 재고 전략을 조정해야 하는 상황에 직면해 있습니다.
세계 백일해 백신 시장의 동향
전 세계 백일해 백신 시장에서는 고령층에서 이 질환의 재유행에 대한 인식이 높아지는 것을 배경으로, 성인 대상 예방접종 프로그램 강화라는 뚜렷한 추세가 나타나고 있습니다. 특히 임산부나 고령자 등 취약 계층에서 면역력 저하와 중증 사례 증가를 보여주는 우려스러운 역학 데이터에 힘입어, 각국 정부는 10대 및 성인의 예방접종 일정에 백일해 추가 접종을 점점 더 많이 포함시키고 있습니다. 공중보건 관련 노력은 면역 격차를 해소하고, 집단 면역을 촉진하며, 차세대 백신 제제에 대한 수요를 창출하는 것을 목적으로 하고 있으며, 성인 대상 정기 건강검진 및 직장내 건강 증진 정책에 백일해 백신 접종을 효과적으로 포함시킴으로써 시장 규모를 확대하고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
개요
시장 역학과 전망
주요 시장 인사이트
세계의 백일해 백신 시장 규모 : 제품 유형별
세계의 백일해 백신 시장 규모 : 백신 유형별
세계의 백일해 백신 시장 규모 : 용도별
세계의 백일해 백신 시장 규모 : 최종사용자별
세계의 백일해 백신 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSA 26.07.22Global Pertussis Vaccine Market size was valued at USD 5.07 Billion in 2024 and is poised to grow from USD 5.26 Billion in 2025 to USD 7.09 Billion by 2033, growing at a CAGR of 3.8% during the forecast period (2026-2033).
The global pertussis vaccine market is poised for significant growth due to the harmonization of regulatory frameworks across various economies. This trend facilitates quicker market entry and reduces development costs for manufacturers, resulting in higher investments in vaccine candidates. Streamlined approval processes by key regulatory bodies enhance the attractiveness of acellular formulations, exemplified by strategic partnerships between biotech firms and vaccine manufacturers in emerging markets. Such collaborations not only expand access to at-risk populations but also create robust revenue streams that support resilience and foster research and development initiatives within the sector, ultimately driving the market forward and improving public health outcomes worldwide.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pertussis Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pertussis Vaccine Market Segments Analysis
Global pertussis vaccine market is segmented by product type, vaccine type, application, end user and region. Based on product type, the market is segmented into DTaP (diphtheria, tetanus, acellular pertussis), Tdap (tetanus, diphtheria, pertussis (adult booster)), whole-cell pertussis vaccines (wP) and combination vaccines (including pertussis antigen). Based on vaccine type, the market is segmented into acellular pertussis (aP) and whole-cell pertussis (wP). Based on application, the market is segmented into pediatric immunization, adolescent booster, adult booster and maternal immunization. Based on end user, the market is segmented into hospitals & clinics, government immunization programs and private healthcare facilities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Pertussis Vaccine Market
The Global Pertussis Vaccine market is experiencing significant growth driven by heightened public awareness of the severe complications associated with pertussis, especially among newborns. As health campaigns and media reports shed light on this issue, both parents and healthcare providers are becoming increasingly focused on ensuring vaccinations are administered. This demand for safe and effective pertussis vaccines is encouraging manufacturers to enhance their production capabilities and innovate new formulations. As the overall immunization framework gains broader acceptance, this creates a positive feedback loop, facilitating growth across various regions and enabling improved public health outcomes and sustained disease control initiatives.
Restraints in the Global Pertussis Vaccine Market
The global market for pertussis vaccines is hindered by ongoing concerns among certain caregiver groups regarding vaccine safety, coupled with misconceptions surrounding pertussis immunization. These apprehensions result in delays or outright refusals in vaccination schedules, ultimately diminishing overall market demand. The lack of confidence in vaccines discourages investment in new product development and hampers the success of public health initiatives aimed at controlling the disease. Consequently, manufacturers encounter unpredictable sales patterns, while healthcare systems must allocate additional resources for educational campaigns, stifling market growth. This uncertainty also complicates long-term planning for distribution networks, requiring companies to adjust their inventory strategies based on varying regional uptake.
Market Trends of the Global Pertussis Vaccine Market
The Global Pertussis Vaccine market is witnessing a notable trend towards enhanced adult immunization programs, driven by a growing recognition of the disease's resurgence among older populations. Governments are increasingly incorporating pertussis boosters into vaccination schedules for teens and adults, spurred by alarming epidemiological data indicating diminishing immunity and a rise in severe cases, particularly in vulnerable groups like pregnant women and the elderly. Public health initiatives aim to bridge immunity gaps, promote herd protection, and stimulate demand for next-generation vaccine formulations, effectively embedding pertussis vaccinations within routine adult health visits and workplace health initiatives, thereby broadening the market landscape.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Pertussis Vaccine Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- DTaP (Diphtheria)
- Tetanus
- Acellular (Pertussis)
- Tdap (Tetanus)
- Diphtheria
- Pertussis - Adult Booster
- Whole-Cell Pertussis Vaccines (wP)
- Combination Vaccines (including Pertussis antigen)
Global Pertussis Vaccine Market Size by Vaccine Type & CAGR (2026-2033)
- Market Overview
- Acellular Pertussis (aP)
- Whole-Cell Pertussis (wP)
Global Pertussis Vaccine Market Size by Application & CAGR (2026-2033)
- Market Overview
- Pediatric Immunization
- Adolescent Booster
- Adult Booster
- Maternal Immunization
Global Pertussis Vaccine Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals & Clinics
- Government Immunization Programs
- Private Healthcare Facilities
Global Pertussis Vaccine Market Size & CAGR (2026-2033)
- North America (Product Type, Vaccine Type, Application, End User)
- US
- Canada
- Europe (Product Type, Vaccine Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Vaccine Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Vaccine Type, Application, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Vaccine Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co. Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi Pasteur SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CSL Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Serum Institute of India Pvt. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biological E. Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bharat Biotech International Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Panacea Biotec Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PT Bio Farma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Walvax Biotechnology Co. Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hualan Biological Engineering Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shenzhen Kangtai Biological Products
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Wuhan Institute of Biological Products
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Chongqing Zhifei Biological Products
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mitsubishi Tanabe Pharma
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Emergent BioSolutions Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bavarian Nordic A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioNTech SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Valneva SE
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
